CardioGenics Holdings (CardioGenics Holdings) Debt-to-EBITDA : -0.48 (As of Jan. 2016)

CardioGenics Holdings Debt-to-EBITDA Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
Debt-to-EBITDA		Get a 7-Day Free Trial					-0.01	-	-0.14	-0.08	-0.10

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.11	-0.17	-0.35	-0.06	-0.48

Competitive Comparison of CardioGenics Holdings's Debt-to-EBITDA

For the Diagnostics & Research subindustry, CardioGenics Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Debt-to-EBITDA falls into.

CardioGenics Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

CardioGenics Holdings's Debt-to-EBITDA for the fiscal year that ended in Oct. 2015 is calculated as

CardioGenics Holdings's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2016 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2016) EBITDA data.

CardioGenics Holdings  (OTCPK:CGNH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

CardioGenics Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description